Seer (SEER) Receivables - Accured (2021 - 2022)

Seer (SEER) recorded quarterly Receivables - Accured of $900000.0 in Q3 2022, up 50.0% quarter-over-quarter from $600000.0 in Q2 2022.

Seer (SEER) Receivables - Accured (2021 - 2022) Analysis & Trends

Seer's Receivables - Accured history runs 2 years deep, the most recent figure standing at $900000.0 for Q3 2022.

In Q3 2022, Receivables - Accured changed N/A year-over-year to $900000.0; the TTM figure through Sep 2022 stood at $900000.0 (changed N/A YoY), while the FY2021 annual figure was $300000.0, changed N/A from the prior year.
Receivables - Accured was $900000.0 for Q3 2022 at Seer, up from $600000.0 in the prior quarter.
In the past five years, Receivables - Accured ranged from a high of $900000.0 in Q3 2022 to a low of $300000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Receivables - Accured (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Seer	99.67 Mn	99.67 Mn	982,000.00	-

Download Data